PMC:7074424 / 908-1241
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
23 | 198-201 | Species | denotes | CoV | Tax:11118 |
60 | 241-254 | Species | denotes | Coronaviruses | Tax:11118 |
61 | 256-260 | Species | denotes | CoVs | Tax:11118 |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T129 | 241-254 | NCBITaxon:11118 | denotes | Coronaviruses |
T128 | 256-260 | NCBITaxon:11118 | denotes | CoVs |
T127 | 269-284 | SO:0000984 | denotes | single-stranded |
T126 | 289-295 | SO:0001026 | denotes | genome |
T14 | 61-65 | CHEBI:23888;CHEBI:23888 | denotes | drug |
T13 | 220-225 | CHEBI:23888;CHEBI:23888 | denotes | drugs |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T6 | 10-18 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T7 | 285-288 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T8 | 289-295 | Body_part | denotes | genome | http://purl.org/sig/ont/fma/fma84116 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T8 | 147-148 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T9 | 267-268 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T10 | 330-332 | http://purl.obolibrary.org/obo/CLO_0007074 | denotes | kb |
T11 | 330-332 | http://purl.obolibrary.org/obo/CLO_0051988 | denotes | kb |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T12 | 10-18 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T13 | 61-65 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T14 | 220-225 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T11 | 87-226 | Sentence | denotes | However, the occurrence of frequent recombination events is a major deterrent factor toward the development of CoV-specific vaccines/drugs. |
T12 | 228-240 | Sentence | denotes | Introduction |